Jekler J, Diffey B, Larkö O
Dermatology Department, Sahlgrenska Hospital, Göteborg, Sweden.
J Am Acad Dermatol. 1990 Jul;23(1):49-51. doi: 10.1016/0190-9622(90)70184-j.
The ultraviolet radiation doses received by patients undergoing phototherapy for atopic dermatitis were measured with the polymer film polysulphone. Patients were irradiated with either Philips TL12 fluorescent lamps (UVB/UVC ratio 8.7) or Wolff Helarium lamps (UVB/UVC ratio greater than 1300). From the measured cumulative doses received during an 8-week course of phototherapy, followed by an analysis of the risk of nonmelanoma skin cancer as a consequence of the treatment, it was concluded that phototherapy for atopic dermatitis can be considered safe.
使用聚砜聚合物薄膜测量了接受特应性皮炎光疗的患者所接受的紫外线辐射剂量。患者分别接受飞利浦TL12荧光灯（UVB/UVC比率为8.7）或沃尔夫氦氖灯（UVB/UVC比率大于1300）照射。根据在为期8周的光疗过程中测得的累积剂量，随后分析了该治疗导致非黑素瘤皮肤癌的风险，得出结论：特应性皮炎的光疗可被视为安全的。
